Aerie Pharmaceuticals (AERI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
15.25 +0.01 (+0.07%) 11/18/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 15.25 unch (unch) -
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Operating Expenses | 96,872 | 75,086 | 49,972 | 22,170 | 14,293 |
| Operating Income | -96,872 | -75,086 | -49,972 | -22,170 | -14,293 |
| Other Income | -1,994 | 862 | 1,839 | -8,978 | -685 |
| Pre-tax Income | -98,866 | -74,224 | -48,133 | -31,148 | -14,978 |
| Income Tax | 193 | 139 | N/A | N/A | N/A |
| Net Income Continuous | -99,059 | -74,363 | -48,133 | -31,148 | -14,978 |
| Net Income | $-99,059 | $-74,363 | $-48,133 | $-31,148 | $-14,978 |
| EPS Basic Total Ops | -3.40 | -2.88 | -2.00 | -6.38 | -16.39 |
| EPS Basic Continuous Ops | -3.40 | -2.88 | -2.00 | -6.29 | -15.68 |
| EPS Diluted Total Ops | -3.40 | -2.88 | -2.00 | -6.38 | -16.39 |
| EPS Diluted Continuous Ops | -3.40 | -2.88 | -2.00 | -6.29 | -15.68 |
| EPS Diluted Before Non-Recurring Items | -3.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-95,074 | $-73,959 | $-49,406 | $-18,899 | $-14,096 |